1 week Ago By Defense World Staff
Prudential Financial Inc. lessened its stake in Masimo Co. ( NASDAQ:MASI – Free Report ) by 63.
1% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,451 shares of the medical equipment provider’s stock after selling 4,185 shares during the period. Prudential Financial Inc.
’s holdings in Masimo were worth $405,000 as of its most recent SEC filing. Several other institutional investors and hedge funds have also recently added to or reduced their stakes in MASI. Corient Private Wealth LLC lifted its stake in shares of Masimo by 8,847.
1% in the 4th quarter. Corient Private Wealth LLC now owns 347,683 shares of the medical equipment provider’s stock worth $57,472,000 after acquiring an additional 343,797 shares during the period. Raymond James Financial Inc.
acquired a new position in shares of Masimo during the fourth quarter worth about $33,716,000. Assenagon Asset Management S.A.
raised its holdings in Masimo by 916.1% during the fourth quarter. Assenagon Asset Management S.
A. now owns 216,051 shares of the medical equipment provider’s stock worth $35,713,000 after purchasing an additional 194,788 shares in the last quarter. Great Lakes Advisors LLC acquired a new stake in Masimo in the fourth quarter valued at about $15,824,000.
Finally, Amundi boosted its holdings in Masimo by 363.8% in the 4th quarter. Amundi now owns 111,481 shares of the medical equipment provider’s stock valued at $18,818,000 after purchasing an additional 87,446 shares in the last quarter.
85.96% of the stock is owned by hedge funds and other institutional investors. Analyst Upgrades and Downgrades A number of equities analysts have recently issued reports on the company.
Raymond James increased their target price on Masimo from $170.00 to $194.00 and gave the stock an “outperform” rating in a research note on Friday, December 27th.
Needham & Company LLC reissued a “hold” rating on shares of Masimo in a report on Wednesday, February 26th. Piper Sandler boosted their target price on shares of Masimo from $210.00 to $215.
00 and gave the stock an “overweight” rating in a research report on Wednesday, February 26th. Finally, Wells Fargo & Company increased their price target on shares of Masimo from $193.00 to $205.
00 and gave the company an “overweight” rating in a report on Wednesday, February 26th. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $194.
80. Masimo Trading Up 13.4 % Shares of MASI stock opened at $164.
57 on Thursday. Masimo Co. has a fifty-two week low of $101.
61 and a fifty-two week high of $194.88. The company has a quick ratio of 1.
11, a current ratio of 2.01 and a debt-to-equity ratio of 0.50.
The business has a fifty day simple moving average of $171.45 and a 200-day simple moving average of $163.95.
The stock has a market cap of $8.89 billion, a P/E ratio of 113.50 and a beta of 1.
28. Masimo ( NASDAQ:MASI – Get Free Report ) last posted its earnings results on Tuesday, February 25th. The medical equipment provider reported $1.
80 earnings per share for the quarter, beating the consensus estimate of $1.42 by $0.38.
The firm had revenue of $600.70 million during the quarter, compared to the consensus estimate of $593.35 million.
Masimo had a net margin of 3.85% and a return on equity of 14.98%.
On average, analysts forecast that Masimo Co. will post 4.1 earnings per share for the current fiscal year.
Insiders Place Their Bets In related news, Director Craig B. Reynolds sold 2,053 shares of the stock in a transaction on Friday, March 14th. The stock was sold at an average price of $166.
13, for a total transaction of $341,064.89. Following the sale, the director now owns 16,581 shares of the company’s stock, valued at $2,754,601.
53. This trade represents a 11.02 % decrease in their ownership of the stock.
The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website . Also, COO Bilal Muhsin sold 30,000 shares of the company’s stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $167.
49, for a total transaction of $5,024,700.00. Following the completion of the transaction, the chief operating officer now owns 24,172 shares in the company, valued at approximately $4,048,568.
28. This trade represents a 55.38 % decrease in their ownership of the stock.
The disclosure for this sale can be found here . 9.70% of the stock is currently owned by company insiders.
Masimo Profile ( Free Report ) Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. See Also Five stocks we like better than Masimo What Are Dividend Champions? How to Invest in the Champions Quantum Computing: The $6.
5 Billion Opportunity You Can’t Ignore How to Most Effectively Use the MarketBeat Earnings Screener Are Tariffs Threatening Disney’s Comeback Story? What is the Dow Jones Industrial Average (DJIA)? Is Alphabet a Generational Buying Opportunity at These Levels? Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. ( NASDAQ:MASI – Free Report ).
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter ..
